- The Phoenix Community for ApoE4 carriers
- Posts
- You know you're APOE4. That's half the story (Phoenix Expert Q&A)
You know you're APOE4. That's half the story (Phoenix Expert Q&A)
23andMe told you you're an APOE4 carrier, but that's like knowing you're in a storm without having a weather map.
23andMe told you you're an APOE4 carrier, but that's like knowing you're in a storm without having a weather map.
Here's what they didn't tell you:
Your APOE4 status interacts with hundreds of other genetic variants. Some amplify your risk. Others might actually protect you. And most carriers have no idea which camp they're in.
That's why this month's Phoenix Expert Q&A hits different.
I sat down with Kian Sadeghi, Founder of Nucleus, to decode what whole genome sequencing reveals that consumer genetic tests miss—and more importantly, how to turn that data into protocols that actually move the needle.
What we covered:
The hidden genetic variants that modify APOE4 risk (minute 12:34)
Why some APOE4/4 carriers never develop Alzheimer's (minute 18:45)
How to build precision protocols based on your complete genetic profile (minute 25:12)
The specific genes that determine whether keto helps or hurts (minute 31:08)
Watch the full Q&A here:
About our partnership philosophy: We always maintain 100% independence. We never have any financial incentives to share about partners. We always ask our partners to pass on any affiliate fees straight back to you as member discounts.
Because being unbiased matters when we are dealing with ApoE4.
Exclusive Phoenix discount: Use code PHOENIX10 for 10% off whole genome sequencing with Nucleus
Not a member yet? This is exactly why we built the Phoenix Community: to turn overwhelming genetic information into clear, actionable protocols.
Stay sharp,
Kevin
P.S. We are still in the “Founding Member” stage where we waive all recurring fees to join the Phoenix. We will switch soon to a monthly / yearly subscription fee for all new members as soon as we release our Phoenix Experiment module.
Our cutting edge tech leverages AI and digital twins technology to help you find the interventions (and dosage) that works for you. It is based on guided structured n=1 experiments and community data on what works for people similar to you.
You can learn more about our Alpha here.